Table 1 Baseline characteristics
QD → BID (N = 29) | BID → QD (N = 32) | P Value | Overall (N = 61) | |
|---|---|---|---|---|
Age (years) | 60.9 ± 9.8 | 61.1 ± 8.4 | 0.925 | 61.0 ± 9.0 |
Onset age | 51.7 ± 10.8 | 51.8 ± 7.0 | 0.857 | 51.7 ± 8.9 |
Sex (M:F) | 11:18 | 13:19 | 1.000 | 24:37 |
mUPDRS | 20.0 ± 9.5 | 22.5 ± 8.6 | 0.170 | 21.3 ± 9.0 |
Hoehn and Yahr stage | 2.1 ± 0.5 | 2.4 ± 0.7 | 0.063 | 2.2 ± 0.6 |
Ropinirole PR dose after titration | 8.9 ± 5.6 | 11.0 ± 5.7 | 0.128 | 10.0 ± 5.7 |
LEDD | 894.0 ± 392.8 | 865.9 ± 361.7 | 0.879 | 879.2 ± 373.9 |
Epworth Sleep Scale | 6.1 ± 5.5 | 6.2 ± 5.9 | 0.353 | 6.1 ± 5.6 |
Sleep questionnaire | ||||
Overall sleep quality | 3.8 ± 2.6 | 2.9 ± 2.7 | 0.232 | 3.4 ± 2.7 |
Nocturnal off-symptoms | 2.5 ± 2.8 | 3.4 ± 3.7 | 0.659 | 3.0 ± 3.3 |
Early morning off symptoms | 2.9 ± 2.7 | 3.0 ± 3.9 | 0.721 | 3.0 ± 3.8 |